Breast cancer (BC), one of the most widespread and devastating diseases affecting women
worldwide, presents a significant public health challenge. This review explores the emerging …

Inflammatory breast cancer (IBC) is the most aggressive and fatal clinical presentation of
breast cancer. Despite the term “inflammatory”, based on the clinical presentation, IBC is …

Opinion statement Inflammatory breast cancer (IBC) is a rare but aggressive subtype of
breast cancer that has a propensity for locoregional recurrence and distant metastasis and is …

Background Although the clinical signs of inflammatory breast cancer (IBC) resemble acute
inflammation, the role played by infiltrating immune and stromal cells in this aggressive …

Breast cancer (BC) is currently the most common malignant tumour in women and one of the
leading causes of their death around the world. New and increasingly personalised …

Background Inflammatory breast cancer (IBC) is an aggressive and rare phenotype of breast
cancer, which has a poor prognosis. Thus, it is necessary to establish a novel predictive …

Background Breast cancer (BRCA) is the malignant tumor with the highest incidence rate
among women in the world, and its mortality rate ranks second. The purpose of our study is …

Among inflammatory breast cancer (IBC) patients, over one‐third have HER2‐
overexpressing (HER2+) tumors. Pathologic complete response (pCR) rates to neoadjuvant …